Galenica AG/€GALE
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Galenica AG
Galenica AG is a healthcare company based in Switzerland, with a core focus on the health and pharmacy sector. The company operates through two main segments: Health & Beauty and Services. The Health & Beauty segment includes the operation of pharmacies and the distribution of health products, while the Services segment provides logistics and related services for the Swiss healthcare sector. Founded in 1927, Galenica has evolved to become a key player in the Swiss market with a comprehensive network and infrastructure that facilitate efficient healthcare distribution. Its strategic positioning is enhanced by its extensive logistics capabilities and strong presence within Switzerland, headquartered in Bern.
Ticker
€GALE
Sector
Primary listing
XGAT
Employees
6,577
Headquarters
Bern, Switzerland
Website
Galenica AG Metrics
BasicAdvanced
€5.2B
26.01
€4.01
0.33
€2.48
1.19%
Price and volume
Market cap
€5.2B
Beta
0.33
52-week high
€105.30
52-week low
€80.41
Average daily volume
64K
Dividend rate
€2.48
Financial strength
Current ratio
1.147
Quick ratio
0.688
Long term debt to equity
52.386
Total debt to equity
70.088
Dividend payout ratio (TTM)
63.56%
Interest coverage (TTM)
16.85%
Profitability
EBITDA (TTM)
295.523
Gross margin (TTM)
12.17%
Net profit margin (TTM)
4.37%
Operating margin (TTM)
5.47%
Effective tax rate (TTM)
17.31%
Revenue per employee (TTM)
€696,110
Management effectiveness
Return on assets (TTM)
4.45%
Return on equity (TTM)
12.11%
Valuation
Price to earnings (TTM)
26.007
Price to revenue (TTM)
1.134
Price to book
3.18
Price to tangible book (TTM)
69.21
Price to free cash flow (TTM)
19.274
Free cash flow yield (TTM)
5.19%
Free cash flow per share (TTM)
5.409
Dividend yield (TTM)
2.38%
Forward dividend yield
1.19%
Growth
Revenue change (TTM)
5.48%
Earnings per share change (TTM)
-1.11%
3-year revenue growth (CAGR)
4.86%
10-year revenue growth (CAGR)
3.57%
3-year earnings per share growth (CAGR)
3.09%
10-year earnings per share growth (CAGR)
8.38%
3-year dividend per share growth (CAGR)
4.35%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Galenica AG stock?
Galenica AG (GALE) has a market cap of €5.2B as of March 14, 2026.
What is the P/E ratio for Galenica AG stock?
The price to earnings (P/E) ratio for Galenica AG (GALE) stock is 26.01 as of March 14, 2026.
Does Galenica AG stock pay dividends?
Yes, the Galenica AG (GALE) stock pays dividends to shareholders. As of March 14, 2026, the dividend rate is €2.48158 and the yield is 1.19%. Galenica AG has a payout ratio of 63.56% on a trailing twelve-month basis.
When is the next Galenica AG dividend payment date?
The next Galenica AG (GALE) dividend payment date is unconfirmed.
What is the beta indicator for Galenica AG?
Galenica AG (GALE) has a beta rating of 0.33. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.